Cargando…
Molecular and Cellular Heterogeneity in Rheumatoid Arthritis: Mechanisms and Clinical Implications
Rheumatoid arthritis is an autoimmune disease that exhibits significant clinical heterogeneity. There are various treatments for rheumatoid arthritis, including disease-modifying anti-rheumatic drugs (DMARDs), glucocorticoids, non-steroidal anti-inflammatory drugs (NSAIDs), and inflammatory cytokine...
Autores principales: | Zhao, Jianan, Guo, Shicheng, Schrodi, Steven J., He, Dongyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660630/ https://www.ncbi.nlm.nih.gov/pubmed/34899757 http://dx.doi.org/10.3389/fimmu.2021.790122 |
Ejemplares similares
-
Cuproptosis and cuproptosis–related genes in rheumatoid arthritis: Implication, prospects, and perspectives
por: Zhao, Jianan, et al.
Publicado: (2022) -
Absent in melanoma 2 (AIM2) in rheumatoid arthritis: novel molecular insights and implications
por: Zhao, Jianan, et al.
Publicado: (2022) -
DNA Methylation of T Lymphocytes as a Therapeutic Target: Implications for Rheumatoid Arthritis Etiology
por: Zhao, Jianan, et al.
Publicado: (2022) -
Understanding the function of the GABAergic system and its potential role in rheumatoid arthritis
por: Shan, Yu, et al.
Publicado: (2023) -
Role of the granzyme family in rheumatoid arthritis: Current Insights and future perspectives
por: Zheng, Yixin, et al.
Publicado: (2023)